• Journal of Chest Surgery
• /
• 제30권11호
• /
• pp.1154-1158
• /
• 1997

활막육종은 관절, 활액낭, 건초 부위에서 발생하는 흔하지 않은 악성 간엽 종양이다. 발생 부위는 전형적으로 사지, 특히 하지에서 호발한다. 복벽이나 흉벽에서도 발생하며 드물지만 두경부에서도 발생한다. 본 병원(삼성의료원) 에서는 17세 여자에서 발생한 늑골의 활막육종 1례를 치험하였다. 수술적 치료로서 우측 두 번째 늑골 종양을 포함하여 첫 번째, 세 번째 늑골 일부를 흉벽과 함께 절제하는 광범위 절제술을 시행하였고, 수술 후 별다른 문제없이 퇴원하였으나, 외래 추적 도중 흉골과 양측 폐에 종양 재발이 발견되어 항암제 치료를 실시하였다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제13권2호
• /
• pp.473-477
• /
• 2012

Introduction: The esophagus squamous cell carcinoma (ESCC) is one of the most deadly malignances, and a current challenge is the development of effective therapeutic agents. Our present work addressed the effect of HIF-$1{\alpha}$ siRNA alone or in combination with cisplatin on the growth of ESCC in nude mice. Materials and Methods: Xenografts were established by inoculating ESCC TE-1 cells in nude mice, and transplanted tumors were treated with HIF-$1{\alpha}$ siRNA, cisplatin alone or together. Growth was assessed by measuring tumor volume. HIF-$1{\alpha}$ mRNA and protein expression were detected using RT-PCR and immunohistochemistry, respectively. Apoptosis of ESCC TE-1 cells was analyzed by flow cytometry. Results: In our nude mice model, HIF-$1{\alpha}$ siRNA effectively inhibited the growth of transplanted ESCC, downregulating HIF-$1{\alpha}$ mRNA and protein expression, and inducing ESCC TE-1 cell apoptosis. Notably when combinated with cisplatin, HIF-$1{\alpha}$ siRNA showed synergistic interaction in suppressing tumor growth. Furthermore, the proportion of apoptotic cells in HIF-$1{\alpha}$ siRNA plus cisplatin group was significantly higher than that in cisplatin or HIF-$1{\alpha}$ siRNA-treated groups (P<0.05). Conclusions: Down-regulated HIF-$1{\alpha}$ expression induced by siRNA could effectively suppress the growth of transplanted ESCC $in$ $vivo$. HIF-$1{\alpha}$ siRNA could enhance the cytotoxicity of cisplatin, which suggests that a combination of these two agents may have potential for therapy of advanced ESCC.

• Journal of Chest Surgery
• /
• 제38권2호
• /
• pp.168-171
• /
• 2005

고립성 섬유성 종양은 주로 흉막에서 발생하는 드문 종양으로 중피하 중간엽에서 기원하며 드물게 흉막 외에서 발생하기도 한다. 많은 경우에서 증상이 없이 우연히 발견되나 다른 중요 장기를 침범하거나 종양의 크기가 커질 경우 증상이 나타나기도 한다. 일반적으로 진단은 영상의학적 검사와 세침흡인을 통한 생검으로 하며 면역조직화학검사를 시행하여 더 정확히 판별할 수 있다 대부분의 경우 양성의 경과를 보이며 병변의 완전한 제거 여부가 가장 중요한 예후 인자가 된다고 알려져 있다. 저자들은 우하엽에 발생한 폐실질 내에 생긴 고립성 섬유성 종양을 채기 절제술로 치험하여 이에 보고하는 바이다

• Journal of Chest Surgery
• /
• 제22권2호
• /
• pp.357-363
• /
• 1989

We experienced very rare case of pulmonary blastoma in a 5 year old girl. She complained of right chest pain and productive cough for 3 months. With computerized tomography and echocardiography it is disclosed that huge mediastinal solid tumor is occupied to whole right thoracic cavity and compressed mediastinal structures to left and extended to left atrium. We removed the thoracic tumor and its extended intracardiac portion completely using the technique of intrapericardial pneumonectomy with cardiopulmonary bypass. Postoperatively the patient recovered without any problem and received adjuvant chemotherapy and radiotherapy. But she was succumbed 2 months later because of opportunistic pulmonary infection with pneumocystis carinii.

• Journal of Chest Surgery
• /
• 제29권1호
• /
• pp.99-102
• /
• 1996

Cardiac fibroma is a rare benign tumor of the heart that occurs primarily in infants and children. Prognosis depends on size, extent and site of tumor. Cardiac fibroma may invade the conduction system, papillary muscle and outflw of inflow tract of ventricle. In these situations, its clinical course is very poor Although operative mortality is high, surgical resection is treatment of choice because lethal arrhythmia and sudden death can be developed by the fibroma. A cardiac fibroma was successfully resected from the left ventricular myocardium of a 8 years old male patient in the Department of Thoracic and Cardiovascular Surgery, Chonbuk National University Hospital.

• Journal of Chest Surgery
• /
• 제54권5호
• /
• pp.400-403
• /
• 2021

A 63-year-old patient was admitted with a sternal fracture and mass. On evaluation, most of the body of the sternum had been destroyed by a tumor. Radical resection of the sternum was performed and part of the major pectoral muscles adherent to the sternal tumor was also resected. The chest wall defect was reconstructed with mesh, bone cement, and a titanium rib plate system. Reconstruction with this method seemed to be an appropriate procedure to prevent instability of the chest wall.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권2호
• /
• pp.657-662
• /
• 2014

Background: The epidermal growth factor receptor (EGFR) mutation status of lung cancer is important because it means that EGFR-tyrosine kinase inhibitor treatment is indicated. The purpose of this prospective study is to determine whether EGFR mutation status could be identified with reference to preoperative factors. Materials and Methods: One hundred-forty eight patients with lung cancer (111 adenocarcinomas, 25 squamous cell carcinomas and 12 other cell types) were enrolled in this study. The EGFR mutation status of each lung cancer was analyzed postoperatively. Results: There were 58 patients with mutant EGFR lung cancers (mutant LC) and 90 patients with wild-type EGFR lung cancers (wild-type LC). There were significant differences in gender, smoking status, maximum tumor diameter in chest CT, type of tumor shadow, clinical stage between mutant LC and wild-type LC. EGFR mutations were detected only in adenocarcinomas. Maximum standardized uptake value (SUVmax:$3.66{\pm}4.53$) in positron emission tomography-computed tomography of mutant LC was significantly lower than that ($8.26{\pm}6.11$) of wild-type LC (p<0.0001). Concerning type of tumor shadow, the percentage of mutant LC was 85.7% (6/7) in lung cancers with pure ground glass opacity (GGO), 65.3%(32/49) in lung cancers with mixed GGO and 21.7%(20/92) in lung cancers with solid shadow (p<0.0001). For the results of discriminant analysis, type of tumor shadow (p=0.00036) was most significantly associated with mutant EGFR. Tumor histology (p=0.0028), smoking status (p=0.0051) and maximum diameter of tumor shadow in chest CT (p=0.047) were also significantly associated with mutant EGFR. The accuracy for evaluating EGFR mutation status by discriminant analysis was 77.0% (114/148). Conclusions: Mutant EGFR is significantly associated with lung cancer with pure or mixed GGO, adenocarcinoma, never-smoker, smaller tumor diameter in chest CT. Preoperatively, EGFR mutation status can be identified correctly in about 77 % of lung cancers.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권4호
• /
• pp.2273-2276
• /
• 2013

Objectives: This study employed proteomic profiling to identify specific tumor markers that might improve early diagnosis of lung squamous cell carcinoma. Methods: Serum samples were isolated from 30 patients with stage I lung squamous cell carcinoma and 30 age-and gender-matched healthy controls, and proteomic profiles were obtained by matrix-assisted laser desorption ionization time of flight mass spectrometry. Results: Three highly expressed potential tumor markers were identified in the sera of stage I lung squamous cell carcinoma patients, with molecular weights of 3261.69, 3192.07, and 2556.92 Da. One protein peak with molecular weight 3261.69 Da was chosen as the candidate biomarker and identified as a fibrinogen alpha chain through a search of the IPI, NCBI or SWISS-PROT protein databases. Conclusion: As a potential tumor biomarker, fibrinogen alpha chain may be applicable for the early diagnosis and prognosis of lung squamous cell carcinoma patients.

• Radiation Oncology Journal
• /
• 제6권2호
• /
• pp.295-300
• /
• 1988

Chordoma is a malignant tumor arising from the primitive notochord involving the axial skeleton. It usually occurs at sacrococcygeal and besisphenoidal area but only rarely does at other vertebral areas, especially at the thoracic vertebrae. It has a slow growth rate and is locally aggressive with an extremely high rate of local recurrence. Either surgery or radiation alone often fails to cure the disease and the local failure is the main cause of treatment failure and death. Overall 5 year survival rate is less than $10\%$. Useful palliation or occasional cure can be obtained by the combination of surgery and radiotherapy. After incomplete resection, the tumor requires radiation dose of 7,000 cGy or more over 6-7 weeks for local control. Tumor regression is slow in response to irradiation and continuation of the regression for several months after completion of RT is not unusual. We report a case of chordoma of the thoracic vertebra, the site of extreme rarity, which showed good local control after partial resection and radiation therapy. He is well and alive without any evidence of recurrence after 13 months of treatment with near complete tumor regression.

• Journal of Chest Surgery
• /
• 제41권1호
• /
• pp.145-148
• /
• 2008

염증성 근섬유모세포종은 드문 질환이며 인체의 거의 모든 위치에서 발생할 수 있다. 흉부영역에서 염증성 근섬유모세포종이 주로 발생하는 위치는 폐와 기관지이다. 종격동에서 발생한 염증성 근섬유모세포종은 보고된 경우가 드물다. 흉부 방사선 촬영에서 우연히 발견된 후종격동 종괴를 가진 환자에서 종괴적출술을 시행하였다. 조직검사결과 염증성 근섬유모세포종으로 진단되었고, 결핵 PCR 양성을 보였다. 본 증례에서 결핵이 염증성 근섬유모세포종의 유발인자로 고려될 수 있었다.